Corrigendum to “Endometrial cancer: A review and current management strategies: Part I” [Gynecol Oncol 134 (2014) 385–392]

Burke, William M.; Orr, James W.; Leitao, Mario M.; Salom, Emery; Gehrig, Paola A.; Olawaiye, Alexander; Brewer, Molly; Boruta, David M.; Villella, Jeannine; Herzog, T.J.; Shahin, Fadi Abu

doi:10.1016/j.ygyno.2014.08.035

Cited by 10 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For instance, this can include the structure of organs and blood vessels, physiology of dynamic bioprocess, and bio-distribution of drugs, ranging from the molecular to cellular and/or organ to organism levels. [202][203][204][205] Significant advances have been made over the years in a range of cancer imaging modalities (such as MRI, fluorescence imaging (FLI), computed tomography (CT), ultrasound (US), and photoacoustic imaging (PAI)) which provide structural information. In addition, more modern methods such as positron emission computed tomography (PET) and singlephoton emission computed tomography (SPECT), have been developed, which provide additional information such as physiological characterizations of organs and tissues.…”

Section: Tumor Imagingmentioning

confidence: 99%

Layered double hydroxide-based nanomaterials for biomedical applications

et al. 2022

View full text Add to dashboard Cite

show abstract

Section: Tumor Imagingmentioning

confidence: 99%

Layered double hydroxide-based nanomaterials for biomedical applications

et al. 2022

View full text Add to dashboard Cite

show abstract

“…EC is a type of epithelial malignancy that occurs in endometrial tissue, often in perimenopausal and postmenopausal women (7). With nearly 200,000 new cases being diagnosed each year, EC has come to be considered as one of the most common female reproductive system tumors and the third most common gynecological malignant tumor (second only to ovarian and cervical cancer) (7).…”

Section: Circrnas In Endometrial Cancermentioning

confidence: 99%

Current and Future Roles of Circular RNAs in Normal and Pathological Endometrium

Yang

Chen

et al. 2021

Front. Endocrinol.

View full text Add to dashboard Cite

The uterine endometrium, which lines the mammalian uterus, is essential for embryo implantation. This lining undergoes significant changes during sexual and menstrual cycles. The endometrium is also associated with hormone-related diseases such as endometriosis and endometrial cancer. Circular RNAs (circRNAs) play a role in various biological processes. Recent studies have determined that circRNAs function in both normal and pathological endometrial environments. Here, we review high-throughput studies pertaining to circRNAs as well as individual circRNAs active in the endometrium, in order to explore the myriad functions of circRNAs in the endometrium and mechanisms underlying these functions, from panoramic and individual perspectives. Owing to their abundant expression, stability, and small size, circRNAs have displayed potential usefulness as diagnostic markers and treatment targets for endometrial-related diseases. Therefore, the specific role of circRNAs in the endometrium warrants systematic investigation in the future.

show abstract

“…Endometrial cancer is the 4th most common gynecological malignancy in females in industrialized countries, especially for postmenopausal females in the sixth and seventh decades of life. [ 1 , 2 ] In the United States, the number of new cases and related deaths due to endometrial carcinoma were 61,880 and 12,160, respectively, in 2019. [ 2 ] Endometrioid carcinoma has a favorable prognosis, with 5-year disease-specific survival rates of approximately 80%, and the majority of endometrioid carcinomas appear in early stages at the time of diagnosis.…”

Section: Introductionmentioning

confidence: 99%

The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study

Li,

Chen,

2024

Medicine

View full text Add to dashboard Cite

To retrospectively analyze the preoperative and intraoperative influencing factors in predicting the escalation of surgical pathological staging in patients with clinical stage I endometrioid carcinoma. Patients with clinical stage I endometrioid carcinoma at Women’s Hospital, School of Medicine, Zhejiang University, between January 2002 and December 2015 were enrolled in this study. Due to preoperative or intraoperative surgical exploration, the patients with one or more preoperative or intraoperative high-risk factors underwent total hysterectomy, bilateral salpingo-oophorectomy and lymphadenectomy, totaling 535 cases. The preoperative and intraoperative influencing factors that could lead to the escalation of postoperative surgical pathological staging were further analyzed. 1. There were 535 patients diagnosed with clinical stage I endometrioid carcinoma before surgery, 125 patients were upgraded with postoperative pathological staging, for a rate of 23.36%. 2. Kaplan–Meier survival curve analysis showed that the prognosis in postoperative surgical pathological staging upgraded cases was worse than that in nonupgraded cases. The tumor-free survival and overall survival rates in the 2 groups were significantly different (P < .001). 3. Univariate analysis showed that preoperative degree of myometrial infiltration, intraoperative visual myometrial infiltration depth, massive size of tumor (diameter ≥ 4 cm) and preoperative abnormal serum cancer antigen 125 (CA125) level were associated with the escalation of surgical pathological staging (P < .05). Multivariate analysis indicated that massive size of tumor and preoperative serum abnormal CA125 level were independent predictors of whether postoperative pathological staging would be upgraded (P < .05). 4. The receiver operating characteristic curve drawn with the massive size of tumor and/or the preoperative serum CA125 level abnormality could be used to predict the probability of postoperative pathological upstaging. The results showed that the area from the combination of the 2 factors under the receiver operating characteristic curve was 0.723 (95% confidence interval, 0.672–0.773), suggesting that the combination of massive size of tumor and abnormal preoperative serum CA125 level may serve as an influencing factor for predicting the postoperative pathological staging upgrades. The clinical stage I endometrioid carcinoma patients with massive size of tumor and abnormal preoperative serum CA125 level need to be fully evaluated to ensure appropriate management as soon as possible, since they are more likely to experience postoperative pathological staging upgrades.

show abstract

Corrigendum to “Endometrial cancer: A review and current management strategies: Part I” [Gynecol Oncol 134 (2014) 385–392]

Cited by 10 publications

References 0 publications

Layered double hydroxide-based nanomaterials for biomedical applications

Layered double hydroxide-based nanomaterials for biomedical applications

Current and Future Roles of Circular RNAs in Normal and Pathological Endometrium

The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study

Contact Info

Product

Resources

About